COVID19 papers from JNU

Pubmed indexed COVID19 papers from JNU
  1. Acharya P et al. Revisiting the levels of Aerosol Optical Depth in south-southeast Asia, Europe and USA amid the COVID-19 pandemic using satellite observations. Environ. Res. 2021: 193, 110514. 
  2. Ahmad S. Potential of age distribution profiles for the prediction of COVID-19 infection origin in a patient group. Inform Med Unlocked 2020: 20, 100364.
  3. Alam A et al. Design of an epitope-based peptide vaccine against the SARS-CoV-2: a vaccine-informatics approach. Brief Bioinform. 2021: 22(2), 1309-1323. 
  4. Awasthi M et al. The Sialoside-Binding Pocket of SARS-CoV-2 Spike Glycoprotein Structurally Resembles MERS-CoV. Viruses 2020: 12(9):909. 
  5. Baru RV. Health systems preparedness during COVID-19 pandemic: China and India. Indian J Public Health: 2020: 64(Supplement):S96-S98.
  6. Bhowmik D et al. Identification of potential inhibitors against SARS-CoV-2 by targeting proteins responsible for envelope formation and virion assembly using docking based virtual screening, and pharmacokinetics approaches. Infect Genet Evol. 2020: 84, 104551
  7. Chakraborti S et al. Evaluating the plausible application of advanced machine learnings in exploring determinant factors of present pandemic: A case for continent specific COVID-19 analysis. Sci. Total Environ. 2021: 765, 142723.
  8. Chaudhary L, B. Singh. Community detection using unsupervised machine learning techniques on COVID-19 dataset. Soc Netw Anal Min 2021: 11(1), 28. 
  9. Chauhan P. Gendering COVID-19: Impact of the Pandemic on Women's Burden of Unpaid Work in India. Gender Issues 2020: 24, 1-25.
  10. Dasgupta R et al. Adopting an intersectoral One Health approach in India: Time for One Health Committees. Indian J Med Res 2021: 153(3), 281-286.
  11. Gupta A et al. COVID-19: Emergence of Infectious Diseases, Nanotechnology Aspects, Challenges, and Future Perspectives. ChemistrySelect 2020: 5(25), 7521-7533 
  12. Gupta I, R Baru. Economics & ethics of the COVID-19 vaccine: How prepared are we? Indian J Med Res 2020: 152(1-2), 153-155
  13. Gupta V et al. Comparative Genomics and Integrated Network Approach Unveiled Undirected Phylogeny Patterns, Co-mutational Hot Spots, Functional Cross Talk, and Regulatory Interactions in SARS-CoV-2. mSystems 2021: 6(1), e00030-21
  14. Imdad K et al. A district-level susceptibility and vulnerability assessment of the COVID-19 pandemic's footprint in India. Spat Spatiotemporal Epidemiol 2021: 36, 100390. 
  15. Jalandra R et al. Strategies and perspectives to develop SARS-CoV-2 detection methods and diagnostics. Biomed Pharmacother 2020:129,110446
  16. Kapasia N et al. Impact of lockdown on learning status of undergraduate and postgraduate students during COVID-19 pandemic in West Bengal, India. Child Youth Serv. Rev. 2020: 116, 105194
  17. Krishnan A, R Dasgupta. Science, policy, people, and public health: What Is COVID-19 teaching us? Indian J Public Health 2020: 64(supple), S 87-S89. 
  18. Kumar A et al. Wuhan to world: the COVID19 pandemic. Front Cell Infect Microbiol. 2021: 11, 596201.
  19. Kumar D et al. Promising inhibitors of main protease of novel corona virus to prevent the spread of COVID-19 using docking and molecular dynamics simulation. J Biomol. Struct Syn. 2020: 22, 1-15.
  20. Kumar D et al. Understanding the binding affinity of noscapines with protease of SARS-CoV-2 for COVID-19 using MD simulations at different temperatures. J Biomol Struct Syn 2021: 39(7), 2659-2672.
  21. Kumar N, Antitussive noscapine and antiviral drug conjugates as arsenal against COVID-19: a comprehensive chemoinformatics analysis. J Biomol Struct Syn. 2020: 20, 1-16.
  22. Kumari M, N. Subbarao. Deep learning model for virtual screening of novel 3C-like protease enzyme inhibitors against SARS coronavirus diseases. Comput Biol Med. 2021: 132, 104317. 
  23. Loesenson R et al. Beyond command and control: A rapid review of meaningful community-engaged responses to COVID-19. Glob Public Health 2021: 18, 1-15. 
  24. Maiti A et al. Exploring spatiotemporal effects of the driving factors on COVID-19 incidences in the contiguous United States. Sustain Cities Soc. 2021: 68, 102784. 
  25. Mandal S et al. Pattern of genomic variation in SARS-CoV-2 (COVID-19) suggests restricted nonrandom changes: Analysis using Shewhart control charts. J Biosci. 2021: 46(1), 11.
  26. Mishra CB et al. Identifying the natural polyphenol catechin as a multi-targeted agent against SARS-CoV-2 for the plausible therapy of COVID-19: an integrated computational approach. Brief Bioinformatics. 2021: 22(2), 1346-1360.
  27. Misra P et al. Nitrogen oxides concentration and emission change detection during COVID-19 restrictions in North India. Sci Rep. 2021: 11(1), 9800. 
  28. Mondal D et al. Increasing risks of domestic violence in India during COVID-19 pandemic. J Psychiatr Res. 2021: 135, 94-95.
  29. Olsen W et al.  Hierarchical Modelling of COVID-19 Death Risk in India in the Early Phase of the Pandemic. Eur J Dev Res 2020: 15, 1-28.
  30. Patel M et al. Coronavirus (SARS-CoV-2) in the environment: Occurrence, persistence, analysis in aquatic systems and possible management. Sci Total Environ. 2021: 765, 142698.
  31. Paul P, D Mondal. Child Marriage in India: A Human Rights Violation During the COVID-19 Pandemic. Asia Pac. J Public Health 2021: 33(1), 162-163.
  32. Paul P, D. Mondal. Maternal and child healthcare in India during COVID-19 pandemic. Midwifery 2021: 92, 102865
  33. Pramanik M et al. Climatic factors influence the spread of COVID-19 in Russia. Int J Environ Health Res 2020: 16, 1-15.
  34. Pramanik M et al. Climatic influence on the magnitude of COVID-19 outbreak: a stochastic model-based global analysis. Int J Environ Health Res: 2020: 22,1-16
  35. Prasad K et al. Brain Disease Network Analysis to Elucidate the Neurological Manifestations of COVID-19. Mol Neurobiol. 2021: 58(5), 1875-1893. 
  36. Priya R, Sujatha V, AYUSH for COVID-19: Science or Superstition? Indian J Public Health 2020 Jun;64(Supplement):S105-S107. 
  37. Roy B, A. Roy. Conducting examinations in India: Emergency, contention and challenges of students amidst covid-19 pandemic. Child Youth Serv Rev 2021: 120, 105768.
  38. Saha S et al. Discovering Potential RNA Dependent RNA Polymerase Inhibitors as Prospective Drugs Against COVID-19: An in silico Approach. Front Pharmacol. 2021: 12, 634047. 
  39. Sarkkar A et al. Public health preparedness and responses to the coronavirus disease 2019 (COVID-19) pandemic in South Asia: a situation and policy analysis. Glob Health J 2020: 4(4), 121-132.
  40. Shafi G et al. Host-dependent molecular factors mediating SARS-CoV-2 infection to gain clinical insights for developing effective targeted therapy. Mol Genet Genomics 2021: 20, 1-11. 
  41. Sharma A et al. BCG vaccination policy and preventive chloroquine usage: do they have an impact on COVID-19 pandemic? Cell Death Dis 2020: 11(7),516
  42. Sharma JR, UC Yadav. COVID-19 severity in obese patients: Potential mechanisms and molecular targets for clinical intervention. Obes Res Clin Pract 2021: 15(2), 163-171.
  43. Singh RKS et al. Diversity of SARS-CoV-2 isolates driven by pressure and health index. Epidemiol Infect 2021: 149, e38. 
  44. Sirohi PR et al. Multiple epitope-based vaccine prediction against SARS-CoV-2 spike glycoprotein. J Biomol. Struct Syn 2000: 27, 1-12
  45. Srivastava A. COVID-19 and air pollution and meteorology-an intricate relationship: A review. Chemosphere 2021: 263, 128297
  46. Srivastava S et al. Computationally validated SARS-CoV-2 CTL and HTL Multi-Patch vaccines, designed by reverse epitomics approach, show potential to cover large ethnically distributed human population worldwide. J Biomol Struct Dyn. 2020: 6, 1-20. 
  47. Srivastava S et al. Structural Basis for Designing Multiepitope Vaccines Against COVID-19 Infection: In Silico Vaccine Design and Validation. JMIR Bioinform Biotech 2020: 19, 1(1), e19371
  48. Verma J, N Subbarao. A comparative study of human betacoronavirus spike proteins: structure, function and therapeutics. Arch Virol 2021: 166(3), 697-714.
  49. Vijayan R, S Gourinath. Structure-based inhibitor screening of natural products against NSP15 of SARS-CoV-2 revealed thymopentin and oleuropein as potent inhibitors. J Protein Protein 2021: 23, 1-10.
  50. Yadav AK et al. The perspectives of biomarker-based electrochemical immunosensors, artificial intelligence and the Internet of Medical Things toward COVID-19 diagnosis and management. Mater Today Chem. 2021: 20, 100443.
  51. Yadav UCS. Vaccines and drugs under clinical trials for prevention and treatment of COVID19. Virus Disease 2021: 32(1), 1-7.